Medical equipment maker Thermo Fisher Scientific Inc on Wednesday forecast annual profit below Wall Street estimates, as it expects that a slump in demand for its services used to make therapeutics and vaccines to continue this year. The company forecast an adjusted profit between $20.95 and $22.00 per share for 2024. Analysts on average were expecting a profit of $22.04 per share in the year, according to LSEG data.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles